| Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study M Slifstein, E Van De Giessen, J Van Snellenberg, JL Thompson, ... JAMA psychiatry 72 (4), 316-324, 2015 | 412 | 2015 |
| Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias G Chételat, J Arbizu, H Barthel, V Garibotto, I Law, S Morbelli, ... The Lancet Neurology 19 (11), 951-962, 2020 | 332 | 2020 |
| Baseline and amphetamine-stimulated dopamine activity are related in drug-naive schizophrenic subjects A Abi-Dargham, E van de Giessen, M Slifstein, LS Kegeles, M Laruelle Biological psychiatry 65 (12), 1091-1093, 2009 | 249 | 2009 |
| Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects BA de Weijer, E van de Giessen, TA van Amelsvoort, E Boot, B Braak, ... EJNMMI research 1, 1-5, 2011 | 212 | 2011 |
| Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3 EM van de Giessen, MML de Win, MWT Tanck, W van den Brink, F Baas, ... Journal of Nuclear Medicine 50 (1), 45-52, 2009 | 173 | 2009 |
| EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 S Morbelli, G Esposito, J Arbizu, H Barthel, R Boellaard, NI Bohnen, ... European journal of nuclear medicine and molecular imaging 47, 1885-1912, 2020 | 157 | 2020 |
| Deficits in striatal dopamine release in cannabis dependence E van de Giessen, JJ Weinstein, CM Cassidy, M Haney, Z Dong, ... Molecular psychiatry 22 (1), 68-75, 2017 | 156 | 2017 |
| Mechanisms of working memory impairment in schizophrenia JX Van Snellenberg, RR Girgis, G Horga, E van de Giessen, M Slifstein, ... Biological psychiatry 80 (8), 617-626, 2016 | 130 | 2016 |
| Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease C Vriend, AH Nordbeck, J Booij, YD van der Werf, T Pattij, P Voorn, ... Movement disorders 29 (7), 904-911, 2014 | 115 | 2014 |
| EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3 E Guedj, A Varrone, R Boellaard, NL Albert, H Barthel, B van Berckel, ... European journal of nuclear medicine and molecular imaging, 1-20, 2022 | 112 | 2022 |
| Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity E van de Giessen, F Celik, DH Schweitzer, W van den Brink, J Booij Journal of Psychopharmacology 28 (9), 866-873, 2014 | 93 | 2014 |
| High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity E Van de Giessen, SE La Fleur, L Eggels, K De Bruin, W Van Den Brink, ... International journal of obesity 37 (5), 754-757, 2013 | 83 | 2013 |
| No association between striatal dopamine transporter binding and body mass index: A multi-center European study in healthy volunteers E de Giessen, S Hesse, MWA Caan, F Zientek, JC Dickson, L Tossici-Bolt, ... NeuroImage, 2012 | 75 | 2012 |
| A Cochrane review on brain [18F]FDG PET in dementia: limitations and future perspectives S Morbelli, V Garibotto, E Van De Giessen, J Arbizu, G Chételat, ... European journal of nuclear medicine and molecular imaging 42, 1487-1491, 2015 | 71 | 2015 |
| Free‐Choice and No‐Choice High‐Fat Diets Affect Striatal Dopamine D2/3 Receptor Availability, Caloric Intake, and Adiposity E Van De Giessen, SE La Fleur, K De Bruin, W Van Den Brink, J Booij Obesity 20 (8), 1738-1740, 2012 | 62 | 2012 |
| Striatal dopamine receptor binding in morbidly obese women before and after gastric bypass surgery and its relationship with insulin sensitivity BA de Weijer, E van de Giessen, I Janssen, FJ Berends, A van de Laar, ... Diabetologia 57, 1078-1080, 2014 | 59 | 2014 |
| Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss EM van der Zwaal, BA de Weijer, EM van de Giessen, I Janssen, ... European Neuropsychopharmacology 26 (7), 1190-1200, 2016 | 50 | 2016 |
| The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis S Morbelli, J Arbizu, J Booij, MK Chen, G Chetelat, DJ Cross, M Djekidel, ... European journal of nuclear medicine and molecular imaging 44, 353-357, 2017 | 47 | 2017 |
| Association of central serotonin transporter availability and body mass index in healthy Europeans S Hesse, E van de Giessen, F Zientek, D Petroff, K Winter, JC Dickson, ... European Neuropsychopharmacology 24 (8), 1240-1247, 2014 | 43 | 2014 |
| Genetic polymorphisms in the DRD2, DRD3, and SLC6A3 gene in elderly patients with delirium BC van Munster, M Yazdanpanah, MWT Tanck, SEJA de Rooij, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153 …, 2010 | 40 | 2010 |
Anissa Abi-DarghamProfessor of Psychiatry at Stony Brook University, Vice Chair for researchVerified email at stonybrookmedicine.edu
